Metraipolis › archive › dc_b93d52dda92b

Efficacy and Safety of Canakinumab Compared With Standard Therapy for the Treatment of Non-Small Cell Lung Cancer (NSCLC): A Systematic Review — Europe PMC PMID:42486074

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42486074
DOI
10.1002/cnr2.70627
License (as archived)
solo-consultazione
Archived
2026-10-18T13:59:42.578Z
SHA-256 of the archived text
588eb530f2aa68a80008264e924d98982be2efaecb68dfee9e205986659d269f
Stable URL of this page
https://metraipolis.com/documento/dc_b93d52dda92b

How to cite

Efficacy and Safety of Canakinumab Compared With Standard Therapy for the Treatment of Non-Small Cell Lung Cancer (NSCLC): A Systematic Review — Europe PMC PMID:42486074 — Europe PMC (en), https://europepmc.org/article/MED/42486074 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b93d52dda92b (Metraipolis archive dc_b93d52dda92b, sha256 588eb530f2aa68a80008264e924d98982be2efaecb68dfee9e205986659d269f)
BibTeX
@misc{dcb93d52dda92b,
  title = {Efficacy and Safety of Canakinumab Compared With Standard Therapy for the Treatment of Non-Small Cell Lung Cancer (NSCLC): A Systematic Review — Europe PMC PMID:42486074},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42486074},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b93d52dda92b; sha256 588eb530f2aa68a80008264e924d98982be2efaecb68dfee9e205986659d269f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42486074. Agents can read the archived copy with the MCP tool read_document.